9.9

CVE-2023-27874: IBM Aspera Faspex XML external entity injection

Modified
Published 21-03-2023Last modified 26-02-2025

Vulnerability summary

CVE-2023-27874 is a critical (CVSS 9.9) vulnerability in ibm aspera_faspex. EPSS estimates a 1.34% chance of exploitation in the next 30 days, higher than 71.6% of scored vulnerabilities.

Priority
Prioritisesevere

Severe, CVSS 9.9 (CVE.org); no exploitation reported by the 5 checked sources; EPSS 1% (FIRST, 10-11-2026)

Source freshness unavailable

How is this decided?
CVSS score
9.9/10
010
Critical · v3.1 (CVE.org)
EPSS score
1.34%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits0No public exploits recorded

Timeline

  1. 21-03-2023
    PublishedVulnerability first disclosed.
  2. 26-02-2025
    Last modifiedVulnerability information updated.

Description

IBM Aspera Faspex 4.4.2 is vulnerable to an XML external entity injection (XXE) attack when processing XML data. A remote authenticated attacker could exploit this vulnerability to execute arbitrary commands. IBM X-Force ID: 249845.

CVSS metrics

2 scores · 2 sources · 1 version

EPSS trend

Probability

1.34%

Chance of exploitation in the next 30 days

Percentile

72%

Versus all other CVEs

30-day change

No change 0.00 pp

From 1.34% on 11-10-2026

11-10-202610-11-2026

Known exploited

Compare KEV catalogs
CISA KEV

Not in the CISA KEV catalog.

ENISA CNW

Not in the ENISA CNW catalog.

CIRCL

Not in the CIRCL catalog.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

Affected systems

Version check

Known conditions: network-reachable, low-privilege account, no user interaction (CVSS vector). Other conditions: not stated in public data.

Ibm1 product
  • aspera_faspex4.4.2 | ≤ 4.4.2 | 4.4.2:patch_level_1 | 4.4.2:patch_level_2

1 vendor · 1 product

References

2 links